Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More

Medchemexpress LLC CZC-8004 | 916603-07-1 | 99.81% | 309.34 | 50 MG
SDP

Supplier:  Medchemexpress LLC HY11113810MM/1ML

Encompass_Preferred

CZC-8004 is a pan-kinase inhibitor that shows potential for cancer research. It exhibits IC50 values of 650 nM for EGFR WT and 437 nM for VEGFR2 V916M. In vitro, CZC-8004 (1 μM) demonstrates specific targeting capabilities towards H1975 cells that possess the VEGFR2 V916M mutation, with observed activity across a panel of human cancer cell lines.

  • Exhibits IC50 values of 650 nM for EGFR WT and 437 nM for VEGFR2 V916M.
  • Can be used in the study of cancer.
  • Shows certain targeting ability to H1975 cells with VEGFR2 V916M mutation.
  • Observed activity across human cancer cell lines CRL2064 (wild type), PC9G (EGFR T790M), H3122CR1 (ALK L1196M), and H1975 (VEGFR2 V916M).

Catalog No. 50-003-44036


May include imposed supplier surcharges.
Only null left
Add to Cart

Product Title
Select an issue

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.